25,249
Views
11
CrossRef citations to date
0
Altmetric
POLYCYSTIC OVARY SYNDROME

Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments

, , , &
Pages 869-874 | Received 16 Dec 2020, Accepted 18 Jul 2021, Published online: 02 Aug 2021

References

  • Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2013;99(1):63.
  • Pasquali R, Antenucci D, Casimirri F, et al. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab. 1989;68(1):173–179.
  • Tarlatzis BC, Fauser BCJM, Legro RS, et al. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Repro. 2008;23(3):462–477.
  • Gibson-Helm ME, Lucas IM, Boyle JA, et al. Women’s experiences of polycystic ovary syndrome diagnosis. Fam Pract. 2014;31(5):545–549.
  • Melo AS, Ferriani RA, Navarro PA. Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice. Clinics. 2015;11:765–769.
  • Sahmay S, Aydogan Mathyk B, Sofiyeva N, et al. Serum AMH levels and insulin resistance in women with PCOS. Eur J Obstet Gynecol Reprod Biol. 2018;224:159–164.
  • Artini PG, Obino MER, Sergiampietri C, et al. PCOS and pregnancy: a review of available therapies to improve the outcome of pregnancy in women with polycystic ovary syndrome. Expert Rev Endocrinol Metabol. 2018;13(2):87–98.
  • Kiddy DS, Hamilton‐Fairley D, Bush A, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol. 1992;36(1):105–111.
  • Balen AH, Dresner M, Scott EM, et al. Should obese women with polycystic ovary syndrome receive treatment for infertility? BMJ. 2006;332(7539):434–435.
  • Crosignani PG, Colombo M, Vegetti W, et al. Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod. 2003;18(9):1928–32.
  • Malik SM. Defining the role of bariatric surgery in polycystic ovarian syndrome patients. World J Diabetes. 2012;3(4):71–79.
  • Escobar-Morreale HF, Santacruz E, Luque-Ramírez M, et al. Prevalence of “obesity-associated gonadal dysfunction” in severely obese men and women and its resolution after bariatric surgery: A systematic review and meta-analysis. Hum Reprod Update. 2017;23(4):390–408.
  • Mahawar KK, Parmar C, Graham Y. One anastomosis gastric bypass: key technical features, and prevention and management of procedure-specific complications. Minerva Chir. 2019;74(2):126–136.
  • Arterburn DE, Telem DA, Kushner RF, et al. Benefits and risks of bariatric surgery in adults: a review. JAMA. 2020;324(9):879–887.
  • Morley LC, Tang T, Yasmin E, et al. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2017;11(11):CD003053.
  • Legro RS, Barnhart HX, Schlaff WD, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med. 2007;356(6):551–566.
  • Johnson NP, Stewart AW, Falkiner J, et al. PCOSMIC: a multi-centre randomized trial in women with polycystic ovary syndrome evaluating metformin for infertility with clomiphene. Hum Reprod. 2010;25(7):1675–1683.
  • Kettel LM, Roseff SJ, Berga SL, et al. Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome. Fertil Steril. 1993;59(3):532–538.
  • Kerin JF, Liu JH, Phillipou G, et al. Evidence for a hypothalamic site of action of clomiphene citrate in women. J Clin Endocrinol Metab. 1985;61(2):265–268.
  • Kumar P, Sait S. Luteinizing hormone and its dilemma in ovulation induction. J Hum Reprod Sci. 2011;4(1):2–7.
  • Dehbashi S, Parsanezhad ME, Alborzi S, et al. Effect of clomiphene citrate on endometrium thickness and echogenic patterns. Int J Gynecol Obstet. 2003;80(1):49–53.
  • Zhao J, Zhang Q, Li Y. The effect of endometrial thickness and pattern measured by ultrasonography on pregnancy outcomes during IVF-ET cycles. Reprod Biol Endocrinol. 2012;10(1):100.
  • Unfer V, Facchinetti F, Orrù B, et al. Myo-inositol. effects in women with PCOS: A meta-analysis of randomized controlled trials. Endocr Connect. 2017;6(8):647–658.
  • Huang S, Du X, Wang R, et al. Ovulation induction and intrauterine insemination in infertile women with polycystic ovary syndrome: A comparison of drugs. Eur J Obstet Gynecol Reprod Biol. 2018;231:117–121.
  • Mejia RB, Summers KM, Kresowik JD, et al. A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome. Fertil Steril. 2019;111(3):571–578.e1.
  • Casper RF. Letrozole versus clomiphene citrate: which is better for ovulation induction? Fertil Steril. 2009;92(3):858–859.
  • Balen AH, Morley LC, Misso M, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016;22(6):687–708.
  • Helmy M, Saleh S, El-Khouly N, et al. Transvaginal needle versus laparoscopic ovarian drilling in drug-resistant polycystic ovary syndrome: a randomized, controlled study. Menoufia Med J. 2019; 32(2):436–440.
  • Weiss NS, Kostova E, Nahuis M, et al. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2019;1(1):CD010290.
  • Gjønnaess H. Late endocrine effects of ovarian electrocautery in women with polycystic ovary syndrome. Fertil Steril. 1998;69(4):697–701.
  • Walls ML, Hart RJ. In vitro maturation. Best Pract Res: Clin Obstetr Gynaec. 2018;53:60–72.
  • Fauser BCJM, Tarlatzis BC, Rebar RW, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28–38.e25.
  • Laganà AS, Rossetti P, Sapia F, et al. Evidence-based and patient-oriented inositol treatment in polycystic ovary syndrome: changing the perspective of the disease. Int J Endocrinol Metab. 2017;15(1):e43695.
  • Atay V, Cam C, Muhcu M, et al. Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. J Int Med Res. 2006;34(1):73–76.
  • Baillargeon JP, Iuorno MJ, Jakubowicz DJ, et al. Metformin therapy increases insulin-stimulated release of D-Chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89(1):242–249.
  • Pundir J, Psaroudakis D, Savnur P, et al. Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials. BJOG. 2018;125(3):299–308.
  • Laffargue P, Gares R, Luscan R, et al. Syndrome de Stein-Leventhal d’origine congénitale probable guéri par résection cunéiforme des ovaires et cortisone; hyperplasie fonctionnelle du stroma ovarien [Stein-Leventhal syndrome of probable congenital origin cured by cuneiform resection of ovaries & cortisone; functional hyperplasia of the ovarian stroma]. Bull Fed Soc Gynecol Obstet Lang Fr. 1957;9(3):317–322.
  • Mitra S, Nayak PK, Agrawal S. Laparoscopic ovarian drilling: an alternative but not the ultimate in the management of polycystic ovary syndrome. J Nat Sci Biol Med. 2015;6(1):40–48.
  • Ferraretti AP, Gianaroli L, Magli MC, et al. Transvaginal ovarian drilling: a new surgical treatment for improving the clinical outcome of assisted reproductive technologies in patients with polycystic ovary syndrome. Fertil Steril. 2001;76(4):812–816.
  • Giampaolino P, Morra I, Tommaselli GA, et al. Post-operative ovarian adhesion formation after ovarian drilling: a randomized study comparing conventional laparoscopy and transvaginal hydrolaparoscopy. Arch Gynecol Obstet. 2016;294(4):791–796.
  • Debras E, Fernandez H, Neveu ME, et al. Ovarian drilling in polycystic ovary syndrome: Long term pregnancy rate. Eur J Obstet Gynecol Reprod Biol X. 2019;4:100093.
  • Giampaolino P, De Rosa N, Della Corte L, et al. Operative transvaginal hydrolaparoscopy improve ovulation rate after clomiphene failure in polycystic ovary syndrome. Gynecol Endocrinol. 2018;34(1):32–35.
  • Ezedinma NA, Phelps JY. Transvaginal hydrolaparoscopy. JSLS. 2012;16(3):461–465.
  • Lebbi I, Ben Temime R, Fadhlaoui A, et al. Ovarian drilling in PCOS: is it really useful? Front Surg. 2015;2:30.
  • Lemieux S, Lewis GF, Ben-Chetrit A, et al. Correction of hyperandrogenemia by laparoscopic ovarian cautery in women with polycystic ovarian syndrome is not accompanied by improved insulin sensitivity or lipid-lipoprotein levels. J Clin Endocrinol Metab. 1999;84:4278–4282.
  • Bordewijk EM, Ng KYB, Rakic L, et al. Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev. 2020;2:CD001122.
  • Seow KM, Juan CC, Hwang JL, et al. Laparoscopic surgery in polycystic ovary syndrome: reproductive and metabolic effects. Semin Reprod Med. 2008;26(1):101–110.
  • Practice Committee of American Society For Reproductive M.Diagnostic evaluation of the infertile female: a committee opinion. Fertil Steril. 2012;98(2):302–307.